Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 438M | 490M | 486M | 439M |
Cost of revenue | 231M | 249M | 249M | 230M |
Gross profit | 207M | 241M | 237M | 209M |
Operating expense | ||||
Research & development | 275M | 281M | 303M | 256M |
Selling general and admin | 49M | 46M | 46M | 47M |
Other operating expenses | — | — | — | — |
Operating income | -117M | -86M | -112M | -94M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | 0 | -2.7B | — |
Pretax income | -99M | -68M | -2.8B | -81M |
Tax provision | 3M | 3M | -78M | 5M |
Net income | -102M | -71M | -2.7B | -86M |
Basic EPS | -0.1 | -0.1 | -3.4 | -0.1 |
Diluted EPS | -0.1 | -0.1 | -3.4 | -0.1 |
Basic average shares | 812M | 811M | 811M | 806M |
Diluted average shares | 812M | 811M | 811M | 806M |
EBITDA | 12M | -2.6B | 2.7B | 33M |
Net income from continuing op. | -102M | -71M | -2.7B | -86M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |